Denver Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$355K Buy
14,745
+555
+4% +$14.5K 0.1% 77
2026
Q1
$398K Buy
14,190
+4,965
+54% +$132K 0.14% 71
2025
Q4
$230K Buy
9,225
+299
+3% +$7.54K 0.08% 84
2025
Q3
$227K Sell
8,926
-2,872
-24% -$70.9K 0.08% 87
2025
Q2
$286K Sell
11,798
-113
-0.9% -$2.63K 0.12% 74
2025
Q1
$302K Sell
11,911
-204
-2% -$5.34K 0.14% 70
2024
Q4
$321K Sell
12,115
-1,284
-10% -$34.8K 0.14% 67
2024
Q3
$388K Sell
13,399
-9
-0.1% -$263 0.18% 58
2024
Q2
$375K Buy
13,408
+483
+4% +$13.3K 0.19% 56
2024
Q1
$359K Buy
12,925
+17
+0.1% +$472 0.18% 57
2023
Q4
$372K Buy
12,908
+467
+4% +$14.1K 0.21% 51
2023
Q3
$413K Buy
12,441
+246
+2% +$8.7K 0.27% 46
2023
Q2
$447K Sell
12,195
-901
-7% -$35.1K 0.31% 42
2023
Q1
$534K Buy
13,096
+112
+0.9% +$4.84K 0.37% 43
2022
Q4
$665K Sell
12,984
-772
-6% -$37K 0.5% 40
2022
Q3
$602K Buy
13,756
+111
+0.8% +$5.39K 0.57% 30
2022
Q2
$715K Buy
+13,645
New +$695K 0.75% 24
2021
Q4
$785K Buy
+13,299
New +$659K 0.75% 18
2021
Q1
$689K Buy
+13,304
New +$472K 0.73% 23

Other funds holding PFE

Denver Wealth Management's PFE Position: Q2 2026 in Review

Denver Wealth Management increased its Pfizer (PFE) stake by 3.9% in Q2 2026, buying an estimated $14.5K and bringing the position to 14,745 shares worth $355K. The position accounts for 0.1% of the portfolio, ranked #77.

Denver Wealth Management first reported a position in PFE in Q1 2021 and has held it in 19 quarters since. The position peaked at $785K in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Denver Wealth Management held 14,745 shares of Pfizer worth $355K as of Q2 2026.
  • Denver Wealth Management bought 555 Pfizer shares in Q2 2026, an estimated $14.5K.
  • Pfizer made up 0.1% of Denver Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Denver Wealth Management first reported a position in Pfizer in Q1 2021 and has held it in 19 quarters since.
  • Denver Wealth Management's Pfizer position peaked at $785K in Q4 2021.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Denver Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.